Metabolite

KNApSAcK Entry

id C00033297
Name Monodemethoxycurcumin / p-Hydroxycinnamoyl feruloyl methane
CAS RN 24939-17-1
Standard InChI InChI=1S/C20H18O5/c1-25-20-12-15(6-11-19(20)24)5-10-18(23)13-17(22)9-4-14-2-7-16(21)8-3-14/h2-12,21,24H,13H2,1H3/b9-4+,10-5+
Standard InChI (Main Layer) InChI=1S/C20H18O5/c1-25-20-12-15(6-11-19(20)24)5-10-18(23)13-17(22)9-4-14-2-7-16(21)8-3-14/h2-12,21,24H,13H2,1H3

Cluster

Phytochemical cluster
KCF-S cluster No. 2164

Link

ChEMBL

By standard InChI
By standard InChI Main Layer

KEGG

By LinkDB

CTD

By CAS RN C050229

Species

Summary

Plant class

class name count
Liliopsida 1

Family

family name count
Zingiberaceae 1

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Curcuma chuanyujin 136212 Zingiberaceae Liliopsida Viridiplantae

Human Protein / Gene in interaction

CTD interaction (22)

compound gene gene name gene description interaction interaction type form reference
pmid
C050229 4363 ABCC1
ABC29
ABCC
GS-X
MRP
MRP1
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 demethoxycurcumin results in decreased activity of ABCC1 protein decreases activity
protein 15885658
16021489
C050229 1244 ABCC2
ABC30
CMOAT
DJS
MRP2
cMRP
ATP-binding cassette, sub-family C (CFTR/MRP), member 2 demethoxycurcumin results in decreased activity of ABCC2 protein decreases activity
protein 15885658
C050229 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein demethoxycurcumin inhibits the reaction [APP protein binds to APP protein] affects binding
/ decreases reaction
protein 19715544
C050229 351 APP
AAA
ABETA
ABPP
AD1
APPI
CTFgamma
CVAP
PN-II
PN2
amyloid beta (A4) precursor protein demethoxycurcumin results in decreased secretion of APP protein decreases secretion
protein 19715544
C050229 836 CASP3
CPP32
CPP32B
SCA-1
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) demethoxycurcumin inhibits the reaction [Peroxynitrous Acid results in increased activity of CASP3 protein] decreases reaction
/ increases activity
protein 19188863
C050229 2730 GCLM
GLCLR
glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) demethoxycurcumin results in increased expression of GCLM mRNA increases expression
mRNA 19188863
C050229 2730 GCLM
GLCLR
glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) demethoxycurcumin results in increased expression of GCLM protein increases expression
protein 19188863
C050229 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) demethoxycurcumin results in increased expression of HMOX1 mRNA increases expression
mRNA 19188863
C050229 3162 HMOX1
HMOX1D
HO-1
HSP32
bK286B10
heme oxygenase (decycling) 1 (EC:1.14.99.3) demethoxycurcumin results in increased expression of HMOX1 protein increases expression
protein 19188863
C050229 3630 INS
IDDM2
ILPR
IRDN
MODY10
insulin demethoxycurcumin results in increased secretion of INS protein increases secretion
protein 19188863
C050229 3791 KDR
CD309
FLK1
VEGFR
VEGFR2
kinase insert domain receptor (a type III receptor tyrosine kinase) (EC:2.7.10.1) demethoxycurcumin affects the expression of KDR mRNA affects expression
mRNA 17960570
C050229 4323 MMP14
MMP-14
MMP-X1
MT-MMP
MT-MMP_1
MT1-MMP
MT1MMP
MTMMP1
WNCHRS
matrix metallopeptidase 14 (membrane-inserted) (EC:3.4.24.80) demethoxycurcumin results in decreased expression of MMP14 protein decreases expression
protein 18495463
C050229 4313 MMP2
CLG4
CLG4A
MMP-II
MONA
TBE-1
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) demethoxycurcumin results in decreased secretion of and results in decreased activity of MMP2 protein modified form decreases activity
/ decreases secretion
protein 18495463
C050229 4318 MMP9
CLG4B
GELB
MANDP2
MMP-9
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) demethoxycurcumin results in decreased secretion of and results in decreased activity of MMP9 protein decreases activity
/ decreases secretion
protein 18495463
C050229 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) demethoxycurcumin results in increased expression of NQO1 mRNA increases expression
mRNA 19188863
C050229 1728 NQO1
DHQU
DIA4
DTD
NMOR1
NMORI
QR1
NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) demethoxycurcumin results in increased expression of NQO1 protein increases expression
protein 19188863
C050229 5328 PLAU
ATF
BDPLT5
QPD
UPA
URK
u-PA
plasminogen activator, urokinase (EC:3.4.21.73) demethoxycurcumin results in decreased secretion of PLAU protein decreases secretion
protein 18495463
C050229 5468 PPARG
CIMT1
GLM1
NR1C3
PPARG1
PPARG2
PPARgamma
peroxisome proliferator-activated receptor gamma demethoxycurcumin binds to PPARG protein affects binding
protein 15713005
C050229 7077 TIMP2
CSC-21K
DDC8
TIMP metallopeptidase inhibitor 2 demethoxycurcumin results in decreased expression of TIMP2 protein decreases expression
protein 18495463
C050229 7422 VEGFA
MVCD1
VEGF
VPF
vascular endothelial growth factor A demethoxycurcumin affects the expression of VEGFA mRNA affects expression
mRNA 17960570
C050229 7490 WT1
AWT1
EWS-WT1
GUD
NPHS4
WAGR
WIT-2
WT33
Wilms tumor 1 demethoxycurcumin results in decreased expression of WT1 mRNA decreases expression
mRNA 18034345
C050229 7490 WT1
AWT1
EWS-WT1
GUD
NPHS4
WAGR
WIT-2
WT33
Wilms tumor 1 demethoxycurcumin results in decreased expression of WT1 protein decreases expression
protein 18034345

Related Disease

Diseases related to CTD interactions

3 disease from interactions of metabolites

MeSH disease OMIM compound disease name evidence type reference
pmid
D000647 C050229 Amnesia therapeutic
18930076
D004487 C050229 Edema therapeutic
18449507
D009361 C050229 Neoplasm Invasiveness therapeutic
18495463